Q. Ji

发表

Identification of HBV-MLL4 Integration and Its Molecular Basis in Chinese Hepatocellular Carcinoma

Q. Ye, G. Zhu, Yun-Qin Chen, 2015, PloS one.

Recurrent amplification of MYC and TNFRSF11B in 8q24 is associated with poor survival in patients with gastric cancer

J. Ji, Lianhai Zhang, Xiaofang Xing, 2015, Gastric Cancer.

Genomic and transcriptome profiling identified both human and HBV genetic variations and their interactions in Chinese hepatocellular carcinoma

Yun-Qin Chen, Z. Ren, Hua Dong, 2015, Genomics data.

Establishing a patient-derived xenograft model of human myxoid and round-cell liposarcoma.

Yingyong Hou, Q. Gu, Q. Ji, 2017, Oncotarget.

An evaluation and recommendation of the optimal methodologies to detect RET gene rearrangements in papillary thyroid carcinoma

Meizhuo Zhang, G. Zhu, Q. Ji, 2015, Genes, chromosomes & cancer.

The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies

R. McCormack, G. Ellison, Chuanhao Tang, 2013, Journal of Clinical Pathology.

DNA Engineered Lymphocyte-Based Homologous Targeting Artificial Antigen-Presenting Cells for Personalized Cancer Immunotherapy.

Zhuang Liu, Q. Gu, Z. Dong, 2022, Journal of the American Chemical Society.

Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies

Yi-long Wu, Xue-Ning Yang, W. Zhong, 2013, Journal of Translational Medicine.

A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies

R. Herbst, P. Elvin, A. Platt, 2015, BMC Cancer.

Preclinical Pharmacology of AZD5363, an Orally Bioavailable Inhibitor of AKT: Pharmacodynamics, Antitumor Activity and Correlation of Monotherapy Activity with Genetic Background

Jing Li, B. Davies, D. Cross, 2012 .

Preclinical Pharmacology of AZD5363, an Inhibitor of AKT: Pharmacodynamics, Antitumor Activity, and Correlation of Monotherapy Activity with Genetic Background

Jing Li, B. Davies, D. Cross, 2012, Molecular Cancer Therapeutics.

The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere

Jing Li, B. Davies, Q. Ji, 2013, Journal of Translational Medicine.

Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models

Yingyong Hou, G. Zhu, Shaohua Lu, 2012, Journal of Translational Medicine.

Preclinical Development Preclinical Pharmacology of AZD 5363 , an Inhibitor of AKT : Pharmacodynamics , Antitumor Activity , and Correlation of Monotherapy Activity with Genetic Background

Jing Li, B. Davies, J. Yates, 2012 .

Tissue-specific transcription reprogramming promotes liver metastasis of colorectal cancer

Z. Lu, Yanmei Zhang, Q. Gu, 2019, Cell Research.

The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere

Jing Li, B. Davies, Q. Ji, 2013, Journal of Translational Medicine.

The oncogenic role of PKCiota gene amplification and overexpression in Chinese non-small cell lung cancer.

Lin Xu, Q. Ji, Jia Huang, 2014, Lung cancer.

Whole genome gene copy number profiling of gastric cancer identifies PAK1 and KRAS gene amplification as therapy targets

Shuqiong Fan, Lili Tang, Jiafu Ji, 2014, Genes, chromosomes & cancer.

Prognostic value of a 25-gene assay in patients with gastric cancer after curative resection

J. Ji, Lianhai Zhang, Xiaofang Xing, 2017, Scientific Reports.

Cathepsin S-mediated autophagic flux in tumor-associated macrophages accelerate tumor development by promoting M2 polarization

J. Shao, Q. Ji, Min Yang, 2014, Molecular Cancer.

Oncogenic HER2 fusions in gastric cancer

J. Ji, Lianhai Zhang, G. Zhu, 2015, Journal of Translational Medicine.

Cathepsin S-mediated autophagic flux in tumor-associated macrophages accelerate tumor development by promoting M2 polarization

J. Shao, Q. Ji, Jie Du, 2014, Molecular Cancer.

FGFR2 Gene Amplification in Gastric Cancer Predicts Sensitivity to the Selective FGFR Inhibitor AZD4547

J. Ji, Lianhai Zhang, E. Kilgour, 2013, Clinical Cancer Research.

Predictive Biomarkers and Personalized Medicine FGFR 2 Gene Ampli fi cation in Gastric Cancer Predicts Sensitivity to the Selective FGFR Inhibitor AZD 4547

J. Ji, Lianhai Zhang, E. Kilgour, 2013 .

High T790M detection rate in TKI-naive NSCLC with EGFR sensitive mutation: truth or artifact?

G. Zhu, Q. Ji, Lei Zhong, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

EGFR mutation status and its impact on survival of Chinese non-small cell lung cancer patients with brain metastases

Zheng Hu, G. Zhu, Q. Ji, 2014, Tumor Biology.

Translating the Therapeutic Potential of AZD4547 in FGFR1-Amplified Non–Small Cell Lung Cancer through the Use of Patient-Derived Tumor Xenograft Models

Roman K. Thomas, Paul D. Smith, E. Kilgour, 2012, Clinical Cancer Research.

Proliferative and Antiapoptotic Signaling Stimulated by Nuclear-Localized PDK1 Results in Oncogenesis

F. Liu, Luzhe Sun, W. Ogawa, 2012, Science Signaling.

Development of Serous Ovarian Cancer is Associated with the Expression of Homologous Recombination Pathway Proteins

Q. Ji, Li Chen, Qingqing Ye, 2014, Pathology & Oncology Research.

Abstract 1643: AZD4547, a potent and selective inhibitor of FGF-receptor tyrosine kinases 1, 2 and 3, inhibits the growth of FGF-receptor 2 driven gastric cancer modelsin vitroandin vivo

E. Kilgour, Q. Ji, X. Su, 2011 .

The Hippo pathway effector TAZ induces TEAD-dependent liver inflammation and tumors

Thijs J. Hagenbeek, Matthew T. Chang, G. Hatzivassiliou, 2018, Science Signaling.

Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models

Yingyong Hou, G. Zhu, Shaohua Lu, 2012, Journal of Translational Medicine.

Genomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical development

Hongyang Wang, Q. Gu, Bin Zhang, 2015, Oncotarget.

Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies

Yi-long Wu, Xue-Ning Yang, W. Zhong, 2013, Journal of Translational Medicine.

Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma

M. Teufel, D. Zopf, Q. Gu, 2017, Oncotarget.

Genetic amplification of PPME1 in gastric and lung cancer and its potential as a novel therapeutic target

Jing Li, Z. Qian, Q. Ji, 2014, Cancer biology & therapy.

Prognostic value of a 25-gene assay in patients with gastric cancer after curative resection

J. Ji, Lianhai Zhang, Xiaofang Xing, 2017, Scientific Reports.

Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma

Yingyong Hou, G. Zhu, Z. Qian, 2015, BMC Cancer.

Retrospective evaluation of RET biomarker status and outcome to vandetanib in four phase III randomized NSCLC trials.

R. Herbst, P. Elvin, A. Platt, 2013 .

Oncogenic HER2 fusions in gastric cancer

J. Ji, Lianhai Zhang, L. Tang, 2015, Journal of Translational Medicine.